Inconsistencies in reporting of renal elimination among NOACs: the case of apixaban

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

Originalsprog	Engelsk
Tidsskrift	Pharmacoepidemiology and Drug Safety
Vol/bind	25
Udgave nummer	3
Sider (fra-til)	346-348
ISSN	1053-8569
DOI	https://doi.org/10.1002/pds.3916
Status	Udgivet - mar. 2016

Dokumenter og links

@article{9f9759676ace49fb9e3273ecff7e4013,

title = "Inconsistencies in reporting of renal elimination among NOACs: the case of apixaban",

author = "Maja Hellfritzsch and Per Damkier and Anton Potteg{\aa}rd and Thor Gr{\o}nlykke and Grove, {Erik L}",

year = "2016",

month = mar,

doi = "10.1002/pds.3916",

language = "English",

volume = "25",

pages = "346--348",

journal = "Pharmacoepidemiology and Drug Safety",

issn = "1053-8569",

publisher = "JohnWiley & Sons Ltd.",

number = "3",

}

TY - JOUR

T1 - Inconsistencies in reporting of renal elimination among NOACs

T2 - the case of apixaban

AU - Hellfritzsch, Maja

AU - Damkier, Per

AU - Pottegård, Anton

AU - Grønlykke, Thor

AU - Grove, Erik L

PY - 2016/3

Y1 - 2016/3

U2 - 10.1002/pds.3916

DO - 10.1002/pds.3916

M3 - Comment/debate

C2 - 26932584

VL - 25

SP - 346

EP - 348

JO - Pharmacoepidemiology and Drug Safety

JF - Pharmacoepidemiology and Drug Safety

SN - 1053-8569

IS - 3

ER -